All melanomas are associated with an initial tumor, but sometimes the location is difficult to ascertain.
All melanomas are associated with an initial tumor, but sometimes the location is difficult to ascertain.
You may have heard about a new medication that was recently FDA approved for cutaneous squamous cell carcinoma (CSCC). Libtayo (cemiplimab-rwlc) is a type of immunotherapy called a checkpoint blockade inhibitor, and it’s the first one approved to treat certain cases of CSCC. This is exciting news, so let’s break down how this new drug works and whom it might help.
Your eyes can focus on a tiny splinter in the finger of a squirming child, a stop sign in the distance or stars blinking light-years away. You can roll your eyes, flirt with them, do a double-take and express joy or despair without words. When you think about how amazing your eyes are, wouldn’t you do anything to protect them?
What happens to your biopsy tissue sample after your dermatologist ships it off to the lab?
Knowing when and what to biopsy is an important skill set for a dermatologist, but getting an accurate diagnosis is still a complicated process. That’s where a dermatopathologist comes in.
One in five Americans will develop skin cancer by the age of 70. We spoke to an expert to better understand where most skin cancers are found.
Both a precancer and an atypical mole may look unusual, but each has unique characteristics. An expert explains the differences.
In the fight against skin cancer, men are way behind the women. What can we do to help those with the Y chromosome catch up?
My dermatologist would like to biopsy a mole on my forearm. I know this involves removing some skin — should I be concerned about the pain?
The term “mole mapping” most commonly refers to the monitoring process for a patient who is at a high-risk for developing melanoma.
